Literature DB >> 22285588

Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.

Andrea T Borchers1, M Eric Gershwin.   

Abstract

Giant cell arteritis is a chronic vasculitis affecting large and medium-sized arteries, most commonly the temporal and other cranial arteries. Temporal artery biopsy has long been the gold standard for establishing the diagnosis of giant cell arteritis. There is growing evidence that simultaneous color Doppler and duplex ultrasonography of temporal arteries of GCA patients represents a valid alternative for this somewhat invasive procedure. Ultrasonography and other imaging modalities such as magnetic resonance imaging and positron emission tomography have also provided evidence that involvement of the aorta and its proximal branches is much more common in giant cell arteritis than previously appreciated; it will be important to clarify whether these patients need to be treated more aggressively. It has long been known that patients with giant cell arteritis face a markedly increased risk of developing aortic aneurysms and of dying from aortic dissection. This raises important questions as to whether patients should be screened regularly for extra-cranial large-vessel involvement and whether and how treatment of patients with positive screening results should be adjusted. In this review we discuss the pathophysiology of this disease and also the issues of epidemiology and sex differences.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285588     DOI: 10.1016/j.autrev.2012.01.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  54 in total

Review 1.  Cytokine gene considerations in giant cell arteritis: IL10 promoter polymorphisms and a review of the literature.

Authors:  Lorena Alvarez-Rodriguez; Marcos Lopez-Hoyos; Eugenio Carrasco-Marín; Gaurav Tripathi; Pedro Muñoz Cacho; Cristina Mata; Jaime Calvo-Alen; Maite Garcia-Unzueta; Elena Aurrecoechea; Victor Manuel Martinez-Taboada
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

2.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Authors:  J Antonio Aviña-Zubieta; Vidula M Bhole; Neda Amiri; Eric C Sayre; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

Review 3.  Updates in the Diagnosis and Management of Giant Cell Arteritis.

Authors:  Surabhi Uppal; Mohanad Hadi; Sheetal Chhaya
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-08       Impact factor: 5.081

4.  [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].

Authors:  P M Villiger
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

Review 5.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

6.  Association between giant cell arteritis and thyroid dysfunction in a "real life" population.

Authors:  Yarden Yavne; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Endocrine       Date:  2017-06-16       Impact factor: 3.633

Review 7.  Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Matthew J Koster; Kenneth J Warrington; Eric L Matteson
Journal:  Rheumatol Int       Date:  2016-08-30       Impact factor: 2.631

8.  A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis.

Authors:  Katharina Luisa Stengl; Ralph Buchert; Hans Bauknecht; Jan Sobesky
Journal:  BMJ Case Rep       Date:  2013-03-01

9.  Cryptococcal Meningitis in A Patient With Giant Cell Arteritis.

Authors:  Jin Lv; Qiankun Zhang
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

Review 10.  The influence of ageing on the development and management of rheumatoid arthritis.

Authors:  Annemieke M H Boots; Andrea B Maier; Piet Stinissen; Pierre Masson; Rik J Lories; Filip De Keyser
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.